Reported 73,080,000 shares, up 8,080,000 (12.4%) from the prior quarter.
Reported value 1.8%; share count 12.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-09-30 | 51119475 |
| 2023-12-31 | 54514900 |
| 2024-03-31 | 32865350 |
| 2024-06-30 | 28569518 |
| 2024-09-30 | 0 |
| 2024-12-31 | 6940733 |
| 2025-03-31 | 49632535 |
| 2025-06-30 | 84641050 |
| 2025-09-30 | 0 |
| 2026-03-31 | 77115420 |
| 2026-06-30 | 78157560 |
| 2026-09-30 | 79565850 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 73,080,000 | +8,080,000 (12.4%) | 4.92% | $79,565,850 | 2026-11-13 | |
| Q2 2026 | Added | 65,000,000 | +5,000,000 (8.3%) | 5.57% | $78,157,560 | 2026-08-14 | |
| Q1 2026 | New | 60,000,000 | +60,000,000 (0.0%) | 5.54% | $77,115,420 | 2026-05-13 | |
| Q3 2025 | Reduced | 0 | -65,000,000 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | Added | 65,000,000 | +22,000,000 (51.2%) | 4.26% | $84,641,050 | 2025-08-14 | |
| Q1 2025 | Added | 43,000,000 | +36,500,000 (561.5%) | 2.86% | $49,632,535 | 2025-05-15 | |
| Q4 2024 | New | 6,500,000 | +6,500,000 (0.0%) | 0.35% | $6,940,733 | 2025-02-18 | |
| Q3 2024 | Reduced | 0 | -26,500,000 (-100.0%) | 0 | $0 | 2024-11-14 | |
| Q2 2024 | Reduced | 26,500,000 | -8,500,000 (-24.3%) | 1.48% | $28,569,518 | 2024-08-14 | |
| Q1 2024 | Reduced | 35,000,000 | -20,000,000 (-36.4%) | 1.73% | $32,865,350 | 2024-05-15 | |
| Q4 2023 | Unchanged | 55,000,000 | 0 (0.0%) | 2.83% | $54,514,900 | 2024-02-14 | |
| Q3 2023 | New | 55,000,000 | +55,000,000 (0.0%) | 2.99% | $51,119,475 | 2023-11-14 |
Who else reported the position
55 managers reported ALNYLAM PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| AMUNDI | Unchanged | 5,000,000 | 0 | 0.11% | $540,369,010 | 13 qtrs |
| STEELHEAD PARTNERS LLC This report | Added | 73,080,000 | +8,080,000 | 4.92% | $79,565,850 | 3 qtrs |
| BNP PARIBAS FINANCIAL MARKETS | Added | 190,841 | +42,978 | 0.02% | $59,027,857 | 12 qtrs |
| SONA ASSET MANAGEMENT US LLC | New | 45,440,000 | +45,440,000 | 1.33% | $49,464,030 | 1 qtr |
| DeepCurrents Investment Group LLC | Added | 26,000,000 | +2,000,000 | 0.81% | $28,292,000 | 3 qtrs |
| FMR LLC | Unchanged | 0 | 0 | < 0.01% | $19,879,096 | 13 qtrs |
| MACKAY SHIELDS LLC | Reduced | 14,813,000 | -21,000 | 0.58% | $16,039,422 | 13 qtrs |
| MANUFACTURERS LIFE INSURANCE COMPANY THE | Added | 14,400,000 | +600,000 | 0.01% | $15,868,800 | 6 qtrs |
| ADVENT CAPITAL MANAGEMENT DE | Added | 14,521,000 | +13,671,000 | 0.36% | $15,736,137 | 2 qtrs |
| BNP Paribas Asset Management Holding S A | Added | 9,550,000 | +9,516,632 | 0.01% | $10,477,417 | 11 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- NOTE 1.000% 9/1
Voting authority reported
- Sole
- 73,080,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.